Staar Surgical Swiss Manufacturing Facility Ready For AquaFlow Production
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical expects to receive FDA approval of its AquaFlow extra-ocular collagen-based glaucoma drainage device in the next two-to-five weeks.